• 1
    De Rossi A, Masiero S, Giaquinto C et al. Dynamics of viral replication in infants with vertically acquired human immunodeficiency virus type 1 infection. J Clin Invest 1996; 97:32330.
  • 2
    Luzuriaga K, Wu H, McManus M et al. Dynamics of human immunodeficiency virus type 1 replication in vertically infected infants. J Virol 1999; 73:3627.
  • 3
    Giorgi JV, Hultin LE, McKeating JA et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 1999; 179:85970.
  • 4
    Sankaran S, Guadalupe M, Reay E et al. Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1-infected nonprogressors. Proc Natl Acad Sci USA 2005; 102:98605.
  • 5
    Valdez H, Lederman MM. Cytokines and cytokine therapies in HIV infection. AIDS Clin Rev 1997–1998:187228.
  • 6
    Behbahani H, Walther-Jallow L, Klareskog E et al. Proinflammatory and type 1 cytokine expression in cervical mucosa during HIV-1 and human papillomavirus infection. J Acquir Immune Defic Syndr 2007; 45:919.
  • 7
    Brenchley JM, Price DA, Schacker TW et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12:136571.
  • 8
    Mehandru S, Poles MA, Tenner-Racz K et al. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 2004; 200:76170.
  • 9
    Purswani M, Johann-Liang R, Cervia J, Noel GJ. Effect of changing antiretroviral therapy on human immunodeficiency virus viral load: experience with fifty-four perinatally infected children. Pediatr Infect Dis J 1999; 18:5126.
  • 10
    Gibb DM, Newberry A, Klein N, De Rossi A, Grosch-Woerner I, Babiker A. Immune repopulation after HAART in previously untreated HIV-1-infected children. Paediatric European Network for Treatment of AIDS (PENTA) Steering Committee. Lancet 2000; 355:13312.
  • 11
    Picker LJ, Maino VC. The CD4+ T cell response to HIV-1. Curr Opin Immunol 2000; 12:3816.
  • 12
    Lederman MM, Valdez H. Immune restoration with antiretroviral therapies. JAMA 2000; 284:2238.
  • 13
    Pakker NG, Notermans DW, De Boer RJ et al. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat Med 1998; 4:20814.
  • 14
    Kaufmann GR, Zaunders J, Murray J et al. Relative significance of different pathways of immune reconstitution in HIV type 1 infection as estimated by mathematical modeling. AIDS Res Hum Retroviruses 2001; 17:14759.
  • 15
    Ometto L, De Forni D, Patiri F et al. Immune reconstitution in HIV-1-infected children on antiretroviral therapy: role of thymic output and viral fitness. AIDS 2002; 16:83949.
  • 16
    De Rossi A, Walker AS, Klein N, De Forni D, King D, Gibb DM. Increased thimic output after initiation of antiretroviral therapy in human immunodeficiency virus type 1-infected children in the Paediatric European Network for treatment of AIDS (PENTA) 5 trial. J Infect Dis 2002; 186:31220.
  • 17
    Resino S, Galan I, Bellon JM, Navarro ML, Leon JA, Munoz-Fernandez MA. Characterizing the immune system after long-term undetectable viral load in HIV-1-infected children. J Clin Immunol 2003; 23:27989.
  • 18
    Fraaij PL, Verweel G, Van Rossum AM et al. Sustained viral suppression and immune recovery in HIV type 1-infected children after 4 years of highly active antiretroviral therapy. Clin Infect Dis 2005; 40:6048.
  • 19
    Chavan S, Bennuri B, Kharbanda M, Chandrasekaran A, Bakshi S, Pahwa S. Evaluation of T cell receptor gene rearrangement excision circles after antiretroviral therapy in children infected with human immunodeficiency virus. J Infect Dis 2001; 183:144554.
  • 20
    Bagnarelli P, Vecchi M, Burighel N et al. Genotypic and phenotypic correlates of the HIV type 1 env gene evolution in infected children with discordant response to antiretroviral therapy. AIDS Res Hum Retroviruses 2004; 20:130613.
  • 21
    Resino S, Galan I, Perez A et al. HIV-infected children with moderate/severe immune-suppression: changes in the immune system after highly active antiretroviral therapy. Clin Exp Immunol 2004; 137:5707.
  • 22
    Ghaffari G, Passalacqua DJ, Caicedo JL, Goodenow MM, Sleasman JW. Two-year clinical and immune outcomes in human immunodeficiency virus-infected children who reconstitute CD4 T cells without control of viral replication after combination antiretroviral therapy. Pediatrics 2004; 114:60411.
  • 23
    Lecossier D, Bouchennet P, Schneider P, Clavel F, Hance AJ. Discordant increases in CD4+ T cells in human immunodeficiency virus-infected patients experiencing virologic treatment failure. Role of changes in thymic output and T cell death. J Infect Dis 2001; 183:100916.
  • 24
    Stoddart CA, Liegler TJ, Mammano F et al. Impaired replication of protease inhibitor-resistant HIV-1 in human thymus. Nat Med 2001; 7:7128.
  • 25
    Hunt P, Deeks S, Bangsberg D et al. The independent effect of drug resistance on T cell activation in HIV infection. AIDS 2006; 20:6919.
  • 26
    Van Baarle D, Kostense S, Van Oers MH, Hamann D, Miedema F. Failing immune control as a result of impaired CD8+ T-cell maturation: CD27 might provide a clue. Trends Immunol 2002; 23:58691.
  • 27
    Schiott A, Lindstedt M, Johansson-Lindbom B et al. CD27 CD4+ memory T cells define a differentiated memory population at both the functional and transcriptional levels. Immunology 2004; 113:36370.
  • 28
    Bekker V, Bronke C, Scherpbier HJ et al. Cytomegalovirus rather than HIV triggers the outgrowth of effector CD8+CD45RA:+CD27 T cells in HIV-1-infected children. AIDS 2005; 19:102534.
  • 29
    Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 2004; 22:74563.
  • 30
    Emu B, Sinclair E, Favre D et al. Phenotypic, functional, and kinetic parameters associated with apparent T cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment. J Virol 2005; 79:1416978.
  • 31
    Jordan KA, Furlan SN, Gonzalez VD et al. CD8 T cell effector maturation in HIV-1-infected children. Virology 2006; 347:11726.
  • 32
    Brenchley JM, Douek DC, Ambrozak DR et al. Expansion of activated human naive T-cells precedes effector function. Clin Exp Immunol 2002; 130:43240.
  • 33
    Wang YM, Wang B, Dyer WB, Lachireddy K, Peng NK, Saksena NK. Evidence for predominance of CCR5-using HIV-1 strains during highly active antiretroviral therapy. Curr HIV Res 2007; 5:22134.
  • 34
    Brenchley JM, Hill BJ, Ambrozak DR et al. T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis. J Virol 2004; 78:11608.
  • 35
    Ye P, Kirschner DE, Kourtis AP. The thymus during HIV disease: role in pathogenesis and in immune recovery. Curr HIV Res 2004; 2:17783.
  • 36
    Mammano F, Trouplin V, Zennou V, Clavel F. Retracing the evolutionary pathways of human immunodeficiency virus type 1 resistance to protease inhibitors: virus fitness in the absence and in the presence of drug. J Virol 2000; 74:852431.
  • 37
    Savarino A, Bottarel F, Malavasi F, Dianzani U. Role of CD38in HIV-1 infection: an epiphenomenon of T-cell activation or an active player in virus/host interactions? AIDS 2000; 14:107989.
  • 38
    Resino S, Seoane E, Gutierrez MD, León JA, Muñoz-Fernández MA. CD4+ T-cell immunodeficiency is more dependent on immune activation than viral load in HIV-infected children on highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2006; 42:26976.
  • 39
    De Martino M, Rossi ME, Azzari C, Gelli MG, Galli L, Vierucci A. Different meaning of CD38 molecule expression on CD4+ and CD8+ cells of children perinatally infected with human immunodeficiency virus type 1 infection surviving longer than five years. Pediatr Res 1998; 43:7528.
  • 40
    De Vries E, De Bruin-Versteeg S, Comans-Bitter WM et al. Longitudinal survey of lymphocyte subpopulations in the first year of life. Pediatr Res 2000; 47:52837.
  • 41
    McCune JM. The dynamics of CD4+ T-cell depletion in HIV disease. Nature 2001; 410:9749.
  • 42
    Douek DC, Brenchley JM, Betts MR et al. HIV preferentially infects HIV-specific CD4+ T cells. Nature 2002; 417:958.
  • 43
    Rosenblatt H, Stanley K, Song L et al. Immunological response to highly active antiretroviral therapy in children with clinically stable HIV-1 infection. J Infect Dis 2005; 192:44555.